Axon Enterprise (NASDAQ:AXON) Stock Rating Reaffirmed by William Blair

Axon Enterprise (NASDAQ:AXON)‘s stock had its “outperform” rating restated by investment analysts at William Blair in a report issued on Wednesday, RTT News reports.

AXON has been the subject of a number of other reports. StockNews.com lowered Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. Morgan Stanley boosted their target price on Axon Enterprise from $250.00 to $285.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 28th. Barclays boosted their target price on Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research note on Thursday, February 29th. Argus initiated coverage on Axon Enterprise in a research note on Wednesday, March 13th. They issued a “buy” rating and a $380.00 target price on the stock. Finally, Needham & Company LLC restated a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research note on Wednesday. Two research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $312.64.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $306.24 on Wednesday. Axon Enterprise has a one year low of $175.37 and a one year high of $329.87. The firm has a market capitalization of $23.11 billion, a price-to-earnings ratio of 133.15 and a beta of 0.93. The business has a 50-day simple moving average of $302.78 and a 200 day simple moving average of $260.58. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The business had revenue of $432.14 million during the quarter, compared to analyst estimates of $418.97 million. On average, research analysts anticipate that Axon Enterprise will post 2.44 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

Institutional investors have recently made changes to their positions in the stock. ICA Group Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $26,000. Trivant Custom Portfolio Group LLC purchased a new stake in shares of Axon Enterprise during the first quarter worth $31,000. First PREMIER Bank purchased a new stake in shares of Axon Enterprise during the first quarter worth $33,000. BKM Wealth Management LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth $32,000. Finally, Blue Bell Private Wealth Management LLC bought a new position in shares of Axon Enterprise in the first quarter worth $41,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.